BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8906525)

  • 1. Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist.
    Schiffrin EL; Deng LY
    J Hypertens; 1996 Oct; 14(10):1247-55. PubMed ID: 8906525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of small arteries of essential hypertensive patients following chronic treatment with once-a-day nifedipine.
    Schiffrin EL
    Cardiology; 1997; 88 Suppl 3():20-6. PubMed ID: 9397289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.
    Schiffrin EL; Pu Q; Park JB
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):105-10. PubMed ID: 11863244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
    Schiffrin EL; Park JB; Pu Q
    J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular remodeling and endothelial function in hypertensive patients: effects of antihypertensive therapy.
    Schiffrin EL
    Scand Cardiovasc J Suppl; 1998; 47():15-21. PubMed ID: 9540129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.
    Schiffrin EL; Park JB; Intengan HD; Touyz RM
    Circulation; 2000 Apr; 101(14):1653-9. PubMed ID: 10758046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.
    Savoia C; Touyz RM; Amiri F; Schiffrin EL
    Hypertension; 2008 Feb; 51(2):432-9. PubMed ID: 18195160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats.
    Sharifi AM; Li JS; Endemann D; Schiffrin EL
    J Hypertens; 1998 Apr; 16(4):457-66. PubMed ID: 9797191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor.
    Schiffrin EL
    J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S13-8. PubMed ID: 8723394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.
    Schiffrin EL; Deng LY; Larochelle P
    Am J Hypertens; 1995 Mar; 8(3):229-36. PubMed ID: 7794571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS; Sharifi AM; Schiffrin EL
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension.
    Park JB; Intengan HD; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):40-5. PubMed ID: 11967798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment.
    Endemann DH; Pu Q; De Ciuceis C; Savoia C; Virdis A; Neves MF; Touyz RM; Schiffrin EL
    Hypertension; 2004 Feb; 43(2):399-404. PubMed ID: 14707158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
    Savoia C; Touyz RM; Volpe M; Schiffrin EL
    Hypertension; 2007 Feb; 49(2):341-6. PubMed ID: 17159079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
    Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.
    Schiffrin EL; Deng LY; Larochelle P
    Hypertension; 1994 Jan; 23(1):83-91. PubMed ID: 8282334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension].
    Schiffrin EL; Deng LY; Larochelle P
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):979-81. PubMed ID: 7755476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.
    Rizzoni D; Muiesan ML; Porteri E; Castellano M; Zulli R; Bettoni G; Salvetti M; Monteduro C; Agabiti-Rosei E
    J Hypertens; 1997 Feb; 15(2):197-204. PubMed ID: 9469796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.